Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| MESA LABORATORIES INC /CO/MLAB · Entity 5221 | Director | April 03, 2020 | April 03, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
MESA LABORATORIES INC /CO/
Report date April 03, 2020 · Filed April 03, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 36,564 |
Ending reported balance
After 2020-04-03 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2020-04-03 · Exercise / conversion · Acquired 200 · Balance 36,274 Row 2 · 2020-04-03 · Exercise / conversion · Acquired 200 · Balance 36,474 Row 3 · 2020-04-03 · Exercise / conversion · Acquired 90 · Balance 36,564 |
| Non Qualified Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $97.78 · Expires 2022-04-01 | Direct | 1,745 |
Reported balance
After 2020-04-03 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2020-04-03 · Other · Disposed 200 · Balance 1,745 F1: 1/5 exercisable on each of the first 5 anniversary dates |
| Non Qualified Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $122.66 · Expires 2023-04-03 | Direct | 1,545 |
Reported balance
After 2020-04-03 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2020-04-03 · Other · Disposed 200 · Balance 1,545 F1: 1/5 exercisable on each of the first 5 anniversary dates |
| Non Qualified Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $142.40 · Expires 2024-04-02 | Direct | 1,455 |
Reported balance
After 2020-04-03 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2020-04-03 · Other · Disposed 90 · Balance 1,455 F1: 1/5 exercisable on each of the first 5 anniversary dates |
Filing footnotes · ownership attribution and instrument terms
F1: 1/5 exercisable on each of the first 5 anniversary dates
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 02, 2018 Filed Apr 4, 2018 17:59 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | GrantCommon Stock | 150 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-18-000015 · primary_doc.xml · nonDerivative · entry 1 Dwyer Robert V · CIK 0001360778 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,671 F1 · shares: Restricted Stock Award that vests 1/5 on June 15, 2019 and 1/5 on the next four anniversary dates thereafter Read SEC document |
| April 02, 2018 Filed Apr 27, 2018 15:51 UTC Amendment | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | GrantNon-Qualified Stock Option · Derivative | 450 | $0.00 Strike: $142.40 | $0.00 |
DisclosureSEC source: 0001228924-18-000019 · primary_doc.xml · derivative · entry 2 Dwyer Robert V · CIK 0001360778 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,590 Underlying: Common Stock · 450 shares Expires 2024-04-02 F1 · derivative.exercise_date: 1/5 exercisable on each of the first five anniversary dates Read SEC document |
| April 02, 2018 Filed Apr 27, 2018 15:51 UTC Amendment | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | GrantCommon Stock | 150 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-18-000019 · primary_doc.xml · nonDerivative · entry 1 Dwyer Robert V · CIK 0001360778 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,421 F2 · shares: Restricted Stock Award that vests 1/5 on June 15, 2019 and 1/5 on the next four anniversary dates thereafter Read SEC document |
| April 02, 2018 Filed Jun 17, 2019 20:41 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | GrantRestricted Stock Unit - 1 · Derivative | 150 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-19-000025 · primary_doc.xml · derivative · entry 2 Dwyer Robert V · CIK 0001360778 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150 Underlying: Common Stock · 150 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock F2 · derivative.exercise_date: Restricted stock units that vest 1/5 on June 15, 2019 and each of the next four anniversary dates thereafter F3 · derivative.expiration_date: Not Applicable Read SEC document |
| March 14, 2018 Filed Mar 19, 2018 12:48 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | SaleCommon Stock | 5,000 | $144.01 | $720,054.50 |
DisclosureSEC source: 0001228924-18-000005 · primary_doc.xml · nonDerivative · entry 1 Dwyer Robert V · CIK 0001360778 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,521 Read SEC document |
| June 16, 2017 Filed Jun 16, 2017 20:49 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | SaleCommon Stock | 7,150 | $139.00 | $993,850.00 |
DisclosureSEC source: 0001228924-17-000029 · primary_doc.xml · nonDerivative · entry 2 Dwyer Robert V · CIK 0001360778 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,521 Read SEC document |
| June 16, 2017 Filed Jun 27, 2017 19:13 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | GiftCommon Stock | 250 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-17-000031 · primary_doc.xml · nonDerivative · entry 1 Dwyer Robert V · CIK 0001360778 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,271 Read SEC document |
| June 14, 2017 Filed Jun 16, 2017 20:49 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | SaleCommon Stock | 4,000 | $140.27 | $561,080.00 |
DisclosureSEC source: 0001228924-17-000029 · primary_doc.xml · nonDerivative · entry 1 Dwyer Robert V · CIK 0001360778 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,671 Read SEC document |
| April 03, 2017 Filed Apr 4, 2017 20:23 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | GrantNon-Qualified Stock Option · Derivative | 830 | $0.00 Strike: $122.66 | $0.00 |
DisclosureSEC source: 0001228924-17-000013 · primary_doc.xml · derivative · entry 1 Dwyer Robert V · CIK 0001360778 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,970 Underlying: Common Stock · 830 shares Expires 2023-04-03 F1 · derivative.exercise_date: 20% exercisable on each of first 5 anniversary dates Read SEC document |
| April 03, 2017 Filed Apr 21, 2017 22:08 UTC Amendment | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | GrantNon-Qualified Stock Option · Derivative | 1,000 | $0.00 Strike: $122.66 | $0.00 |
DisclosureSEC source: 0001228924-17-000023 · primary_doc.xml · derivative · entry 1 Dwyer Robert V · CIK 0001360778 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,140 Underlying: Common Stock · 1,000 shares Expires 2023-04-03 F1 · derivative.exercise_date: 20% exercisable on each of first 5 anniversary dates Read SEC document |
| February 22, 2017 Filed Feb 23, 2017 16:30 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | SaleCommon Stock | 3,300 | $125.14 | $412,962.00 |
DisclosureSEC source: 0001228924-17-000007 · primary_doc.xml · nonDerivative · entry 2 Dwyer Robert V · CIK 0001360778 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,671 Read SEC document |
| February 21, 2017 Filed Feb 23, 2017 16:30 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | SaleCommon Stock | 1,700 | $125.12 | $212,704.00 |
DisclosureSEC source: 0001228924-17-000007 · primary_doc.xml · nonDerivative · entry 1 Dwyer Robert V · CIK 0001360778 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,971 Read SEC document |
| December 15, 2016 Filed Dec 27, 2016 18:10 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Salecommon stock | 1,000 | $134.00 | $134,000.00 |
DisclosureSEC source: 0001228924-16-000052 · primary_doc.xml · nonDerivative · entry 2 Dwyer Robert V · CIK 0001360778 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,671 Read SEC document |
| December 14, 2016 Filed Dec 27, 2016 18:10 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | SaleCommon Stock | 1,002 | $132.13 | $132,394.26 |
DisclosureSEC source: 0001228924-16-000052 · primary_doc.xml · nonDerivative · entry 1 Dwyer Robert V · CIK 0001360778 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,671 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.